:format(webp)/cdn.mskdoctors.com/storage/2024/8/Uq1OBPQi9qHiVHeZuxsmZ2iTRlEVZ7tl.jpg)
Tanvi Verma
3/8/2024
the complex journey ofkneecartilage damage recovery with
Search Filters
Search
Specialties
ACL
Specialties
Cartilage
Specialties
Orthopaedics
:format(webp)/cdn.mskdoctors.com/storage/2024/8/whLfKQyVVXvJJ7avhoM2WKML5rQzdwKp.jpg)
Tanvi Verma
1/8/2024
MACI) is a groundbreakingkneecartilage repair method that
:format(webp)/cdn.mskdoctors.com/storage/2024/8/Uvxq9rKfZbibEHS76vakwEMEKQI5aXij.jpg)
Tanvi Verma
31/7/2024
Kneecartilage damage can cause
:format(webp)/cdn.mskdoctors.com/storage/2024/7/nzebp1kerXixGDSZwLO3WprYgZro0FA8.jpg)
Tanvi Verma
20/7/2024
advanced surgical treatments forkneecartilage repair at MSK
:format(webp)/cdn.mskdoctors.com/storage/2024/7/Eq6DGagAltPY3VSSlUwKSYOvdq16FtVi.jpg)
Tanvi Verma
19/7/2024
the latest advancements inkneecartilage repair at MSK
:format(webp)/cdn.mskdoctors.com/storage/2026/8/mOM8evNOHkiXmiESVwOZGPQ1PHyq8aid.jpg)
Miss Sophie Harris
28/8/2026
anatomical targets within theknee. ChondroFiller is a collagen
:format(webp)/cdn.mskdoctors.com/storage/2026/8/2aQwmM1AYBNyJU4BaVz8KBQ2Vit6dIYs.jpg)
Miss Sophie Harris
26/8/2026
own cartilage-and-bone plugs forkneedefects up to roughly
:format(webp)/cdn.mskdoctors.com/storage/2026/8/o5ovKxl85s6GjqXO0lxghkOnYgKV4rkk.jpg)
Miss Sophie Harris
22/8/2026
AMIC completeskneecartilage repair in a
:format(webp)/cdn.mskdoctors.com/storage/2026/8/HNjIITnLfDPcylo4yz0VBys38PlWW8b6.jpg)
Miss Sophie Harris
19/8/2026
weeks apart. It delayskneereplacement—7.4% progression over a
:format(webp)/cdn.mskdoctors.com/storage/2026/8/5yqtnO9k0Fj59GMzO0kP7LWXrqltF5su.jpg)
Miss Sophie Harris
16/8/2026
Mostkneepain settles with rest
:format(webp)/cdn.mskdoctors.com/storage/2026/8/D2kqxeavVUcZNASzOXi8rxUp6cWpjo8e.jpg)
Miss Sophie Harris
15/8/2026
weight-bearing from damaged innerkneecartilage to the healthier
:format(webp)/cdn.mskdoctors.com/storage/2026/8/FEda3Z8zPavpj6fyME29Nts2lLeujPFQ.jpg)
Miss Sophie Harris
13/8/2026
Established cartilage repair using autologous chondrocytes shows 10–17 year durability for focalkneedefects; mesenchymal stem cell therapies have not been tested in large-scale trials against them.